BangladeshPost placeholder

New Delhi Correspondent
Indian patients who received faulty Articular Surface Replacement (ASR) hip implants (prior to August, 2010) manufactured by the British multinational company Johnson & Johnson will get compensation ranging from Rs 30 lakh to Rs 1.22 crore, the Indian Ministry of Health and Family Welfare has announced.
The new compensation package marks a rise from the base amount of Rs 20 lakh considered earlier taking into account the age of the patients, the risk factor and the degree of disabilities suffered by the patients who underwent surgery and received the faulty hip implants.
The announcement came late on Thursday night after the Indian government approved formula for determination of compensation for those patients who suffered major disabilities after receiving the faulty hip implants manufactured by Johnson & Johnson.
The government accepted the formula prepared by an expert committee, paving the way for patients to secure compensation from Johnson & Johnson in the days to come in a time-bound manner through bank accounts of the affected persons, an official statement said.
An expert committee was constituted by the Ministry under the Chairmanship of Dr. Arun Kumar Agarwal, Ex-Dean and Professor of ENT, Maulana Azad Medical College, New Delhi, to examine the issues relating to faulty ASR hip implants. The committee, after detailed examination of the issue, submitted its report along with its final recommendation, which was accepted by the Indian government.
Johnson & Johnson had initiated a recall of its ASR hip implant across the world in 2010. Following a probe in India, the Drug Controller General of India asked the British firm to extend its medical management programme along with reimbursement of medical cost to India.
Johnson & Johnson had reportedly agreed to pay 2.5 billion dollars to patients in the US in 2013 for the faulty hip implants.